{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:50:49Z","timestamp":1777337449482,"version":"3.51.4"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,4,6]]},"DOI":"10.7759\/cureus.37201","type":"journal-article","created":{"date-parts":[[2023,4,6]],"date-time":"2023-04-06T12:20:40Z","timestamp":1680783640000},"source":"Crossref","is-referenced-by-count":2,"title":["Bleeding Diathesis as the Initial Presentation of Chronic Myeloid Leukemia: A Case Series"],"prefix":"10.7759","author":[{"given":"Farjah H","family":"AlGahtani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leena","family":"Alshaman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghada","family":"ElGohary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aamer","family":"Aleem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatmah S","family":"AlQahtany","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"What is chronic myeloid leukemia? Leukemia types. (2018). Accessed. March 22, 2023: https:\/\/www.cancer.org\/cancer\/chronic-myeloid-leukemia\/about\/what-is-cml.html."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1309\/AJCPUN89CXERVOVH","article-title":"Chronic myelogenous leukemia, BCR-ABL1+","volume":"132","author":"Vardiman JW","year":"2009","unstructured":"Vardiman JW. Chronic myelogenous leukemia, BCR-ABL1+. Am J Clin Pathol. 2009, 132:250-60. 10.1309\/AJCPUN89CXERVOVH","journal-title":"Am J Clin Pathol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-01082-4","article-title":"Characterization of p190-Bcr-Abl chronic myeloid leukemia reveals specific signaling pathways and therapeutic targets","volume":"35","author":"Adnan-Awad S","year":"2021","unstructured":"Adnan-Awad S, Kim D, Hohtari H, et al.. Characterization of p190-Bcr-Abl chronic myeloid leukemia reveals specific signaling pathways and therapeutic targets. Leukemia. 2021, 35:1964-75. 10.1038\/s41375-020-01082-4","journal-title":"Leukemia"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2017.36","article-title":"Differential signaling networks of Bcr-Abl p210 and p190 kinases in leukemia cells defined by functional proteomics","volume":"31","author":"Reckel S","year":"2017","unstructured":"Reckel S, Hamelin R, Georgeon S, et al.. Differential signaling networks of Bcr-Abl p210 and p190 kinases in leukemia cells defined by functional proteomics. Leukemia. 2017, 31:1502-12. 10.1038\/leu.2017.36","journal-title":"Leukemia"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13184","article-title":"Long-term outcome of chronic myeloid leukaemia patients with p210 and p190 co-expression at baseline","volume":"169","author":"Molica M","year":"2015","unstructured":"Molica M, Zacheo I, Diverio D, Alimena G, Breccia M. Long-term outcome of chronic myeloid leukaemia patients with p210 and p190 co-expression at baseline. Br J Haematol. 2015, 169:148-50. 10.1111\/bjh.13184","journal-title":"Br J Haematol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-02-204693","article-title":"Chronic myeloid leukemia (CML) with P190 BCR-ABL: analysis of characteristics, outcomes, and prognostic significance","volume":"114","author":"Verma D","year":"2009","unstructured":"Verma D, Kantarjian HM, Jones D, et al.. Chronic myeloid leukemia (CML) with P190 BCR-ABL: analysis of characteristics, outcomes, and prognostic significance. Blood. 2009, 114:2232-5. 10.1182\/blood-2009-02-204693","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2017.62","article-title":"Clinical and prognostic significance of e1a2 BCR-ABL1 transcript subtype in chronic myeloid leukemia","volume":"7","author":"Gong Z","year":"2017","unstructured":"Gong Z, Medeiros LJ, Cortes JE, et al.. Clinical and prognostic significance of e1a2 BCR-ABL1 transcript subtype in chronic myeloid leukemia. Blood Cancer J. 2017, 7:e583. 10.1038\/bcj.2017.62","journal-title":"Blood Cancer J"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s40880-016-0108-0","article-title":"The Philadelphia chromosome in leukemogenesis","volume":"35","author":"Kang ZJ","year":"2016","unstructured":"Kang ZJ, Liu YF, Xu LZ, et al.. The Philadelphia chromosome in leukemogenesis. Chin J Cancer. 2016, 35:48. 10.1186\/s40880-016-0108-0","journal-title":"Chin J Cancer"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(17)30232-6","article-title":"Epidemiological patterns of leukaemia in 184 countries: a population-based study","volume":"5","author":"Miranda-Filho A","year":"2018","unstructured":"Miranda-Filho A, Pi\u00f1eros M, Ferlay J, Soerjomataram I, Monnereau A, Bray F. Epidemiological patterns of leukaemia in 184 countries: a population-based study. Lancet Haematol. 2018, 5:e14-24. 10.1016\/S2352-3026(17)30232-6","journal-title":"Lancet Haematol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1053\/shem.2003.50034","article-title":"Molecular mechanisms of transformation by the BCR-ABL oncogene","volume":"40","author":"Sattler M","year":"2003","unstructured":"Sattler M, Griffin JD. Molecular mechanisms of transformation by the BCR-ABL oncogene. Semin Hematol. 2003, 40:4-10. 10.1053\/shem.2003.50034","journal-title":"Semin Hematol"},{"key":"ref11","unstructured":"American Cancer Society. phases of chronic myeloid leukemia. (2018). Accessed: March 24, 2023: https:\/\/www.cancer.org\/cancer\/chronic-myeloid-leukemia\/detection-diagnosis-staging\/staging.html."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2015.73","article-title":"The EUTOS population-based registry: incidence and clinical characteristics of 2904 CML patients in 20 European Countries","volume":"29","author":"Hoffmann VS","year":"2015","unstructured":"Hoffmann VS, Baccarani M, Hasford J, et al.. The EUTOS population-based registry: incidence and clinical characteristics of 2904 CML patients in 20 European Countries. Leukemia. 2015, 29:1336-43. 10.1038\/leu.2015.73","journal-title":"Leukemia"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2012.745525","article-title":"Trends in chronic myeloid leukemia incidence and survival in the United States from 1975 to 2009","volume":"54","author":"Chen Y","year":"2013","unstructured":"Chen Y, Wang H, Kantarjian H, Cortes J. Trends in chronic myeloid leukemia incidence and survival in the United States from 1975 to 2009. Leuk Lymphoma. 2013, 54:1411-7. 10.3109\/10428194.2012.745525","journal-title":"Leuk Lymphoma"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/5674193","article-title":"An unusual cause of bleeding in a patient with chronic myeloid leukemia chronic phase","volume":"2019","author":"Kartthik S","year":"2019","unstructured":"Kartthik S, Mandal PK, Abdullah SM. An unusual cause of bleeding in a patient with chronic myeloid leukemia chronic phase. Case Rep Hematol. 2019, 2019:5674193. 10.1155\/2019\/5674193","journal-title":"Case Rep Hematol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-09-180604","article-title":"Tyrosine kinase inhibitor-induced platelet dysfunction in patients with chronic myeloid leukemia","volume":"114","author":"Quint\u00e1s-Cardama A","year":"2009","unstructured":"Quint\u00e1s-Cardama A, Han X, Kantarjian H, Cortes J. Tyrosine kinase inhibitor-induced platelet dysfunction in patients with chronic myeloid leukemia. Blood. 2009, 114:261-3. 10.1182\/blood-2008-09-180604","journal-title":"Blood"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000016984","article-title":"Bleeding with negative coagulation screening test as initial presentation of chronic myelogenous leukemia managed by fresh frozen plasma: a case report","volume":"98","author":"Wang Y","year":"2019","unstructured":"Wang Y, Wang L, Xi Y, Li Z. Bleeding with negative coagulation screening test as initial presentation of chronic myelogenous leukemia managed by fresh frozen plasma: a case report. Medicine (Baltimore). 2019, 98:e16984. 10.1097\/MD.0000000000016984","journal-title":"Medicine (Baltimore)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2022-160132","article-title":"Hematoma or bleeding as initial presentation of chronic myeloid leukemia (CML): review","volume":"140","author":"Ahmed A","year":"2022","unstructured":"Ahmed A, Saeed S, Soliman DS, et al.. Hematoma or bleeding as initial presentation of chronic myeloid leukemia (CML): review. Blood. 2022, 140:12231-2. 10.1182\/blood-2022-160132","journal-title":"Blood"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1177\/1076029619858409","article-title":"TKI-related platelet dysfunction does not correlate with bleeding in patients with chronic phase-chronic myeloid leukemia with complete hematological response","volume":"25","author":"Sener Y","year":"2019","unstructured":"Sener Y, Okay M, Aydin S, Buyukasik Y, Akbiyik F, Dikmen ZG. TKI-related platelet dysfunction does not correlate with bleeding in patients with chronic phase-chronic myeloid leukemia with complete hematological response. Clin Appl Thromb Hemost. 2019, 25:3-7. 10.1177\/1076029619858409","journal-title":"Clin Appl Thromb Hemost"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s12288-020-01376-8","article-title":"A pilot study on probing of imatinib induced platelet dysfunction in patients with chronic myeloid leukemia-chronic phase and absence of associated bleeding manifestation: trying to solve an enigma","volume":"37","author":"De R","year":"2021","unstructured":"De R, Chowdhury R, Dolai TK, Bhar B, Islam MM, Chakrabarty P, Deb S. A pilot study on probing of imatinib induced platelet dysfunction in patients with chronic myeloid leukemia-chronic phase and absence of associated bleeding manifestation: trying to solve an enigma. Indian J Hematol Blood Transfus. 2021, 37:162-6. 10.1007\/s12288-020-01376-8","journal-title":"Indian J Hematol Blood Transfus"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.12659\/AJCR.936266","article-title":"Unilateral subhyaloid hemorrhage as a presenting sign of chronic myeloid leukemia","volume":"23","author":"Almater AI","year":"2022","unstructured":"Almater AI, Alhadlaq GS, Alromaih AZ. Unilateral subhyaloid hemorrhage as a presenting sign of chronic myeloid leukemia. Am J Case Rep. 2022, 23:e936266. 10.12659\/AJCR.936266","journal-title":"Am J Case Rep"},{"key":"ref21","article-title":"Neutrophilic-chronic myeloid leukemia: a case report","volume":"9","author":"Al Ghasham NS","year":"2015","unstructured":"Al Ghasham NS. Neutrophilic-chronic myeloid leukemia: a case report. Int J Health Sci (Qassim). 2015, 9:87-90.","journal-title":"Int J Health Sci (Qassim)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/144985-bleeding-diathesis-as-the-initial-presentation-of-chronic-myeloid-leukemia-a-case-series","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:57:49Z","timestamp":1707508669000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/144985-bleeding-diathesis-as-the-initial-presentation-of-chronic-myeloid-leukemia-a-case-series"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,6]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.37201","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4,6]]}}}